Complications associated with the use of silicone oil in vitreoretinal surgery: A systemic review and meta-analysis.
Valentín-Bravo Fco Javier, García-Onrubia Luis, Andrés-Iglesias Cristina, Valentín-Bravo Eduardo, Martín-Vallejo Javier, Pastor José Carlos, Usategui-Martín Ricardo, Pastor-Idoate Salvador
AI Summary
This meta-analysis found silicone oil increases intraocular hypertension but reduces retinal re-detachment compared to other agents. Clinically, SO's benefits in re-detachment must be weighed against hypertension risk.
Abstract
Silicone oil (SO) still represents the main choice for long-term intraocular tamponade in complicated vitreoretinal surgery. This review compared the complications associated with the use of SO and other vitreous substitutes after pars plana vitrectomy in patients with different underlying diseases. Meta-analysis was conducted in accordance with PRISMA guidelines. We retrieved randomized clinical trials (RCTs), retrospective case-control and cohort studies evaluating the risk of using SO, published between 1994 and 2020, conducting a computer-based search of the following databases: PubMed, Web of Science, Scopus and Embase. Primary outcome was the rate of complications such as intraocular hypertension, retinal re-detachment, unexpected vision loss or hypotony. Secondary outcome was to compare the rate of adverse events of different SO viscosities, especially emulsification. Forty-three articles were included. There were significant differences in intraocular hypertension (p = 0.0002, OR = 1.66; 95% CI = 1.27-2.18) and the rate of retinal re-detachment (p < 0.0009, OR = 0.65; 95% CI = 0.50-0.64) between SO and other agents, including placebo. However, there were no differences in other complication rates. Silicone oil (SO)-emulsification rate was non-significantly higher in low than high SO viscosity, and results from other complications were comparable in both groups. The high quality of most of the studies included in this study is noteworthy, which provides some certainty to the conclusions. Among them is the high variability of the SO residence time. The fact that ocular hypertension and not hypotension is related to SO use. A clear relationship is not found for the so-called unexplained vision loss, which affects a significant percentage of eyes. Re-detachment cases are less if SO is used and that surprisingly there does not seem to be a relationship in the percentage of emulsification between the low- and high-viscosity silicones. All these data warrant more standardized prospective studies.
MeSH Terms
Shields Classification
Key Concepts5
There were significant differences in intraocular hypertension (p = 0.0002, OR = 1.66; 95% CI = 1.27-2.18) between silicone oil (SO) and other agents, including placebo, used for long-term intraocular tamponade in complicated vitreoretinal surgery.
The rate of retinal re-detachment (p < 0.0009, OR = 0.65; 95% CI = 0.50-0.64) was significantly different between silicone oil (SO) and other agents, including placebo, used for long-term intraocular tamponade in complicated vitreoretinal surgery, with re-detachment cases being less if SO is used.
There were no significant differences in other complication rates, besides intraocular hypertension and retinal re-detachment, between silicone oil (SO) and other agents, including placebo, used for long-term intraocular tamponade in complicated vitreoretinal surgery.
Silicone oil (SO)-emulsification rate was non-significantly higher in low than high SO viscosity, and results from other complications were comparable in both groups, when comparing different SO viscosities used for long-term intraocular tamponade in complicated vitreoretinal surgery.
Silicone oil (SO) still represents the main choice for long-term intraocular tamponade in complicated vitreoretinal surgery.
Related Articles5
Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Cohort StudyRepeated fluid-gas exchange for hypotony after vitreoretinal surgery for proliferative vitreoretinopathy.
Case SeriesNovel vitreous substitutes: the next frontier in vitreoretinal surgery.
ReviewIntraoperative massive suprachoroidal hemorrhage during pars plana vitrectomy.
Case SeriesVisual outcomes with 23-gauge transconjunctival sutureless vitrectomy.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.